Literature DB >> 6150318

Induction of ovulation for in-vitro fertilisation using buserelin and gonadotropins.

R N Porter, W Smith, I L Craft, N A Abdulwahid, H S Jacobs.   

Abstract

Mesh:

Substances:

Year:  1984        PMID: 6150318     DOI: 10.1016/s0140-6736(84)92840-x

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  69 in total

1.  Hormonal stimulation for in vitro fertilization: a comparison of fertilization rates and cytogenetic findings in unfertilized oocytes.

Authors:  P De Sutter; M Dhont; D Vandekerckhove
Journal:  J Assist Reprod Genet       Date:  1992-06       Impact factor: 3.412

2.  Improved pregnancy outcome with gonadotropin releasing hormone agonist (GnRH-a) stimulation is due to the improvement in oocyte quantity rather than quality.

Authors:  H C Liu; Y M Lai; O Davis; A S Berkeley; M Graf; J Grifo; J Cohen; Z Rosenwaks
Journal:  J Assist Reprod Genet       Date:  1992-08       Impact factor: 3.412

3.  A case report: successful pregnancy after controlled ovarian hyperstimulation by using short-acting gonadotropin releasing hormone agonist only.

Authors:  Fei Gong; Sufen Cai; Shunji Zhang; Changfu Lu; Ge Lin; Guangxiu Lu
Journal:  J Assist Reprod Genet       Date:  2012-02-09       Impact factor: 3.412

Review 4.  Buserelin. A review of its pharmacodynamic and pharmacokinetic properties, and clinical profile.

Authors:  R N Brogden; M M Buckley; A Ward
Journal:  Drugs       Date:  1990-03       Impact factor: 9.546

5.  Targeted disruption of Nrg1 in granulosa cells alters the temporal progression of oocyte maturation.

Authors:  Ikko Kawashima; Takashi Umehara; Noritaka Noma; Tomoko Kawai; Manami Shitanaka; Joanne S Richards; Masayuki Shimada
Journal:  Mol Endocrinol       Date:  2014-03-20

6.  The addition of norethindrone acetate to leuprolide acetate for ovarian suppression has no adverse effect on ovarian stimulation.

Authors:  E C Ditkoff; R Prosser; R C Zimmermann; S Lindheim; M V Sauer
Journal:  J Assist Reprod Genet       Date:  1997-02       Impact factor: 3.412

7.  Comparison between a single dose of goserelin (depot) and multiple daily doses of leuprolide acetate for pituitary suppression in IVF treatment: a clinical endocrinological study of the ovarian response.

Authors:  Selmo Geber; Liana Sales; Marcos A C Sampaio
Journal:  J Assist Reprod Genet       Date:  2002-07       Impact factor: 3.412

8.  Impact of leuprolide acetate on the response to follicular stimulation for in vitro fertilization in patients with normal basal gonadotropin levels.

Authors:  R G Brzyski; G S Jones; S Oehninger; A A Acosta; C H Kruithoff; S J Muasher
Journal:  J In Vitro Fert Embryo Transf       Date:  1989-10

9.  Vitrification versus slow freezing gives excellent survival, post warming embryo morphology and pregnancy outcomes for human cleaved embryos.

Authors:  Mojtaba Rezazadeh Valojerdi; Poopak Eftekhari-Yazdi; Leila Karimian; Fatemeh Hassani; Bahar Movaghar
Journal:  J Assist Reprod Genet       Date:  2009-06-10       Impact factor: 3.412

10.  Does suppressing luteinising hormone secretion reduce the miscarriage rate? Results of a randomised controlled trial.

Authors:  K Clifford; R Rai; H Watson; S Franks; L Regan
Journal:  BMJ       Date:  1996-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.